Turn Therapeutics Inc. Files 8-K
Ticker: TTRX · Form: 8-K · Filed: Oct 22, 2025 · CIK: 2023016
| Field | Detail |
|---|---|
| Company | Turn Therapeutics Inc. (TTRX) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, name-change
TL;DR
Turn Therapeutics Inc. is the new name for Global Health Solutions, Inc. as of May 10, 2024.
AI Summary
Turn Therapeutics Inc. filed an 8-K on October 22, 2025, reporting a name change from Global Health Solutions, Inc. on May 10, 2024. The company is incorporated in Delaware and its principal executive offices are located in Westlake Village, California.
Why It Matters
This filing indicates a corporate name change, which can signal a rebranding or strategic shift for the company.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not contain information about financial performance or significant business events.
Key Players & Entities
- Turn Therapeutics Inc. (company) — Registrant
- Global Health Solutions, Inc (company) — Former company name
- May 10, 2024 (date) — Date of name change
- October 22, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Westlake Village, California (location) — Principal executive offices
FAQ
What is the new name of the company?
The new name of the company is Turn Therapeutics Inc.
What was the former name of the company?
The former name of the company was Global Health Solutions, Inc.
When did the name change occur?
The name change occurred on May 10, 2024.
What is the filing date of this 8-K?
The filing date of this 8-K is October 22, 2025.
In which state is Turn Therapeutics Inc. incorporated?
Turn Therapeutics Inc. is incorporated in Delaware.
Filing Stats: 490 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2025-10-22 08:06:17
Key Financial Figures
- $0.0001 — ch Registered Common Stock, par value $0.0001 per share TTRX The Nasdaq Stock Mar
Filing Documents
- tm2529242d1_8k.htm (8-K) — 24KB
- tm2529242d1_ex99-1.htm (EX-99.1) — 12KB
- tm2529242d1_ex99-1img01.jpg (GRAPHIC) — 15KB
- 0001104659-25-101410.txt ( ) — 221KB
- ttrx-20251022.xsd (EX-101.SCH) — 3KB
- ttrx-20251022_lab.xml (EX-101.LAB) — 33KB
- ttrx-20251022_pre.xml (EX-101.PRE) — 22KB
- tm2529242d1_8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated October 22, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TURN THERAPEUTICS INC. Date: October 22, 2025 By: /s/ Bradley Burnam Name: Bradley Burnam Title: Chief Executive Officer